Mohammed et al. inferred that genomic variations in PgR represent a typical mechanism for decreases of PgR protein expression, which might induce alterations in the expression patterns of the ER-binding gene, affecting breast tumor proliferation and explaining the poor outcomes of patients with luminal breast cancer [14]. The gene discussed is PGR; the disease is breast carcinoma.